Industry
Featured experience
Endo $6.7 billion merger with Mallinckrodt
We are advising Endo on the transaction
GSK up to $1.15 billion acquisition of IDRx
We are advising GSK on the transaction
Galderma Group CHF2.3 billion ($2.6 billion) IPO
We advised Galderma on its IPO
Convey Holding Parent $186.7 million IPO
We advised the underwriters on the IPO and NYSE listing
Molecular Partners $64 million IPO
We advised the joint book-running managers and underwriters on the IPO and Nasdaq listing
RAPT Therapeutics $143.7 million follow-on offering
We advised the joint book-running managers on the SEC-registered equity offering
CARsgen Therapeutics HK$3.1 billion IPO
We advised CARsgen Therapeutics on its IPO and HKEX listing
Apria $139.7 million stock offering
We advised the underwriters on the SEC-registered equity offering
Mathys sale to DJO
We are advising the Mathys family on the sale
Ayala Pharmaceuticals $20 million at-the-market offering
We advised the sales agent on the stock offering
Oak Street Health $747.2 million secondary offering
We advised the joint book-running managers on the equity offering
Esco Lifesciences $200 million Series A financing
We are advising Esco Lifesciences on its Series A financing
Fresenius Medical Care $1.5 billion notes offering
We advised the initial purchasers on the Rule 144A / Regulation S notes offering